Recombinant Human eNOS Protein，His

Endothelial nitric oxide synthase (eNOS) is a crucial enzyme responsible for the production of nitric oxide (NO), a signaling molecule that plays a vital role in vascular homeostasis, modulation of blood flow, and regulation of blood pressure. The study of eNOS recombinant protein holds significant importance in cardiovascular research due to its involvement in various pathological conditions, including atherosclerosis, hypertension, and endothelial dysfunction. Understanding the structure and function of eNOS through recombinant technology enables researchers to explore its intricate regulatory mechanisms, post-translational modifications, and interactions with other proteins. By generating eNOS in a controlled laboratory setting, scientists can investigate how alterations in its activity impact vascular health and disease. Furthermore, eNOS recombinant proteins provide valuable tools for developing therapeutic strategies aimed at enhancing NO production or improving eNOS function, which could lead to novel interventions for cardiovascular diseases. Recent advances in molecular biology techniques, such as CRISPR and advanced protein engineering, have also facilitated the generation of eNOS variants with modified characteristics, allowing for deeper explorations of its biological functions. Overall, the research on eNOS recombinant proteins is pivotal in elucidating the role of NO in cardiovascular physiology and pathology, ultimately guiding the development of innovative therapies to combat cardiovascular disorders.